DEVELOPMENT OF NEW DRUGS: RESEARCH, LAUNCH AND ACCESS


INSTITUTION: NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS

SCHOOL: SCHOOL OF HEALTH SCIENCES

DEPARTMENT: SCHOOL OF MEDICINE

Taught in Greek language


DURATION (semesters): 3

ECTS (total): 90


TUITION: 3000

Scholarship is offered

CITY: ATHENS


NUMBER OF STUDENTS ACCEPTED: 30

STUDENTS SELECTED BY: Written exams and application evaluation

Part time studying is available

PART TIME DURATION (semesters): 3

OBSERVATION OPTIONS: In Person

TOPICS

Health and Medicine

CONTACT

Master's website

Secretary's e-mail: mscmed@med.uoa.gr

PHONE NUMBER: 2107700220

Send e-mail

DESCRIPTION - ACCEPTED STUDENTS CATEGORIES:

KEYWORDS: CLINICAL RESEARCH, APPROVAL, REGULATORY AUTHORITIES, LAUNCH, EARLY ACCESS, MARKET ACCESS, PRICE NEGOTIATIONS, REIMBURSEMENT, DRUG VIGILANCE.

COMMENTS: Education on the international and local procedures of research, approval, launch and reimbursement of a new drug.

Postgraduate Studies of the Greek Universities

Helpdesk & Knowledge Base: Helpdesk